A fter infection with Leishmania major, mice from the majority of inbred strains develop lesions that resolve spontaneously leaving the animals immune to reinfection. In contrast, mice from few inbred strains (e.g., BALB), referred to as genetically susceptible, develop progressive lesions that do not heal and do not become immune to reinfection. These genetically determined resistance and susceptibility to L. major have been demonstrated to result from the development of CD4 ϩ Th1 and Th2 responses, respectively (1) . Among the many stimuli possibly influencing the maturation of distinct effector cells from common CD4 ϩ T cell precursors, cytokines play a major role (2) (3) (4) (5) . The results obtained in vitro using CD4 ϩ T cells from TCR ␣␤ transgenic mice demonstrating the essential role of IL-12 and IL-4 in Th1 and Th2 cell maturation, respectively, have been validated in vivo using the murine model of infection with L. major (6 -10) . In this context, we have documented a burst of IL-4 mRNA expression in the draining lymph nodes of BALB/c mice within 16 h after infection with L. major (11) . Remarkably, this rapid IL-4 response occurs during the period when neutralizing IL-4 Abs are capable of redirecting protective Th1 development in BALB/c mice (8, 9) . The cognate recognition of a single epitope of the Leishmania homolog of mammalian RACK1 (LACK) 4 (12) was demonstrated to drive this early IL-4 response by a restricted population of MHC class II restricted CD4 ϩ T cells that express the V␤4 V␣8 TCR chains (13) . The causal relationship between this rapid accumulation of IL-4 transcripts and the development of aberrant Th2 responses leading to a susceptible phenotype in BALB/c mice was established (14, 15) . Interestingly, the possibility of modulating this rapid IL-4 response by treatment with either exogenous IL-12 or IFN-␥ (11) suggests that these cells are not irreversibly committed to IL-4 production. In fact, we have recently documented the functional plasticity of these cells in terms of cytokines production (16) . Together, these results suggest that these cells are sensitive to regulatory processes.
In the past few years, the concept that subpopulations of T cells were specialized in the suppression of immune responses has been revisited. Considerable attention has been given to a minor subpopulation of CD4 ϩ T cells constitutively expressing CD25, the ␣-chain of the IL-2R. Both in mice and humans, these cells, named regulatory T cells, have been shown capable of suppressing the proliferation of other T cell populations (reviewed in Refs. 17 and 18) .
The present study was undertaken to determine whether or not, following infection of BALB/c mice with L. major, the early production of IL-4 by LACK-reactive V␤4 V␣8 CD4 ϩ T cells and the resulting Th2 responses were subject to the control of regulatory CD4 
CD25
ϩ T cells may also regulate harmful immune responses to infectious pathogens.
Materials and Methods

Mice
Female BALB/c and C57BL/6 mice were purchased from Harlan Olac (Bicester, U.K.). Female C.B.-17 SCID mice were purchased from IFFACredo (St. Germain sur l'Arbresle, France). All mice were used at 6 -8 wk of age.
Reagents and Abs
Anti-CD3 (145-2C11), anti-FcR (2.4G2), anti-CD25 (PC61) (19) , and anti-IL-4 (11B11) mAbs were affinity purified on a protein A column from hybridoma culture supernatants. Cychrome-and PE-conjugated anti-CD4 (GK1.5), PE-conjugated anti-CD45R/B220 (RA3-6B2), FITC-conjugated anti-CD8 (53-6.7), PE-conjugated anti-CD69 (H1.2F3), and anti-CD62L (MEL-14) were purchased from BD PharMingen (San Diego, CA). Purified, unlabeled, and FITC-conjugated anti-CD25 (5A2) (20) Parasites, infection, and treatment of mice L. major LV 39 (MRHO/Sv/59/P-strain) were maintained in vivo and grown in vitro as described previously (21) . Groups of three to seven mice were infected s.c. in the hind footpads with 3 ϫ 10 6 stationary phase L. major promastigotes in a final volume of 50 l. Mice from designated groups received 1 mg of PC61 mAb i.p. 72 h before infection. Some mice were also treated with anti-IL-4 mAb (11B11) i.p. at indicated doses and time points. Disease progression was monitored using a Vernier caliper to measure footpad size. In designated experiments, footpad tissues were used to create limiting dilutions for quantitation of viable parasite burdens as previously described (22) .
Lymphocyte cultures and detection of cytokines in supernatants
Draining popliteal lymph node cells (5 ϫ 10 6 ) were cultured in a final volume of 1 ml in DMEM supplemented with 5% heat inactivated FCS, 216 g/ml L-glutamine, 5 ϫ 10 Ϫ5 M 2-ME, and 10 mM HEPES at 37°C in an atmosphere of 7% CO 2 in the presence or absence of UV-irradiated L. major promastigotes (1 ϫ 10 6 /ml) or soluble anti-CD3 (2 g/ml). Supernatants were collected at 48 h from cultures stimulated with soluble anti-CD3 or at 72 h for cultures stimulated with Leishmania Ags, and frozen at Ϫ20°C until use. IFN-␥ was measured in supernatants by ELISA as described (23) . Mouse rIFN-␥ (supernatant of L1210 cells transfected with the murine IFN-␥ gene; a gift from Y. Watanabe, Kyoto University, Kyoto, Japan) was used as the standard. The limit of detection of the assay was 10 U/ml. IL-4 was measured by a bioassay using the CTLL-44 cell line (a gift from P. Erb, University of Basel, Basel, Switzerland) as described (24) . Recombinant murine IL-4 secreted by X63Ag-653 cells (a gift from F. Melchers, Basel Institute of Immunology, Basel, Switzerland) was used as the standard. The limit of detection of the assay was 20 pg/ml. For proliferation assays, 5 ϫ 10 5 cells were cultured with UV-irradiated stationary phase L. major promastigotes (1 ϫ 10 6 /ml) or anti-CD3 (0.5 g/ ml) in 200 l DMEM/5% FCS, and were pulsed with 1 Ci of [ 3 H]thymidine for the final 6 h of culture. Harvested cells were measured for radioactivity using a beta scintillation counter.
RNA extraction and competitive PCR
Total mRNA was extracted from popliteal lymph node cells as described (11) . First strand cDNA synthesis was performed using a first strand cDNA synthesis kit according to the manufacturer's directions (Pharmacia, Uppsala, Sweden). The polycompetitor plasmid (pQRS) was used to quantitate amounts of transcripts for IFN-␥, IL-4, and the constitutively expressed hypoxanthine guanine phosphoribosyl transferase gene, using primers and PCR conditions as described (25) . Briefly, the cDNA was used as a template in the presence of serial 5-fold dilutions of pQRS. After separation of the PCR products by electrophoresis in agarose gel containing ethidium bromide, the ratio of IL-4 or IFN-␥ transcripts to hypoxanthine guanine phosphoribosyl transferase transcripts was calculated. The results are expressed as the fold increase in cytokine mRNA in mice infected with L. major compared with that in noninfected, but otherwise similarly treated, control mice.
Cell sorting and reconstitution of SCID mice
CD4
ϩ CD25 ϩ cells were depleted from total spleen cells of naive wild-type BALB/c mice using magnetic cell sorting columns (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's directions. In brief, total spleen cells depleted of RBC by lysis in Tris-buffered NH 4 Cl solution were first stained with anti-CD25 mAb 5A2 for 20 min on ice. Following washing, cells were resuspended with magnetic microbeads that had been conjugated with goat anti-rat IgG Ab and the CD25-depleted population was negatively selected after immobilization with a magnet. This procedure generally resulted in the removal of CD4 ϩ CD25 ϩ cells from the spleen cell suspension to background levels of Ͻ1.5% of total CD4 ϩ cells, as detected by flow cytometry with subsequent staining using PC61, a second anti-CD25 mAb that binds to a different epitope on the IL-2R␣ molecule (19, 20) . In some experiments, depletion was performed with a combination of FITC-labeled 5A2 and anti-FITC microbeads. The efficiency of depletion was similar.
C.B.-17 SCID mice were bled in the tail vein and PBMC were obtained by Ficoll-Hypaque centrifugation. The PBMC were stained for CD4, CD8, and B220 and screened by flow cytometry. SCID mice that had Ͻ1% peripheral B or T cells were reconstituted i.v. with designated numbers of spleen cells from wild-type BALB/c mice. In some experiments, SCID mice were reconstituted with CFSE-labeled spleen cells as above.
Cell counting
Cells were either counted using a Neubauer chamber or using the FACS; cell suspensions were resuspended in a volume of 300 l, and 10 5 bacterial count microbeads (Molecular Probes) were added to each tube and cells were then analyzed by FACS. Gates were assigned to the microbeads and lymphocytes by forward and size scatter characteristics. The ratio of beads to lymphocytes was determined for each specimen from the electronic counts on FACScan.
Statistics
Statistical analysis was done using the two-tailed t test for unpaired data. The estimation of the frequency of parasites by limiting dilution was calculated by the Taswell method using the program Estimfree (26).
Results
Depletion of CD4
ϩ CD25 ϩ regulatory T cells before infection with L. major exacerbates the development of lesions in BALB/c mice To study the role of the CD4 ϩ
CD25
ϩ regulatory T cells in vivo, BALB/c mice were treated once with 1 mg of ␣CD25 mAb PC61 i.p. (19) . Seventy-two hours following such treatment, the proportion of CD4 ϩ CD25 ϩ T cells dropped from around 10% to below 2% of the CD4 ϩ T cell population in lymph nodes (data not shown). The percentage of CD4 ϩ CD25 ϩ T cells within the lymph nodes remained low for over 10 days. The percentage of the CD4 ϩ CD25 ϩ subpopulation in peripheral blood was also reduced to around 2% of the circulating CD4 ϩ T cells (data not shown). This depletion was also long-lasting as reported by others (27) .
Compared with similarly infected control BALB/c mice, mice treated with 1 mg of PC61 mAb 72 h before infection with 3 ϫ 10 6 L. major promastigotes developed significantly larger lesions (Fig.  1A ) that contained higher numbers of parasites (Fig. 1B) . The number of parasites measured in lesions of PC61-treated BALB/c mice was consistently significantly higher than that measured in lesions of BALB/c mice in five different experiments ( p ϭ 0.019). The development of severe lesions in BALB/c mice depleted of CD4 ϩ CD25 ϩ T cells was correlated with an enhanced IL-4-producing Th2 response. Results in Fig. 1C show that 15 days after infection with L. major the amounts of IL-4 transcripts in draining lymph nodes are already five times higher in BALB/c mice depleted of CD4 ϩ CD25 ϩ cells than in similarly infected control BALB/c mice. Comparable results were obtained when supernatants of L. major-activated lymph node cells were analyzed for the accumulation of IL-4 ( Fig. 1D) . This difference in IL-4 production between CD4
ϩ CD25 ϩ cell-depleted and normal BALB/c mice was also observed at later times after infection (data not shown). In most experiments, the level of IFN-␥ in supernatants of cultures from draining lymph nodes of mice depleted of CD4 ϩ CD25 ϩ cells was equivalent to, or only slightly higher, than that measured in cultures of lymph nodes from nondepleted BALB/c mice ( Fig. 1D) . Depletion of CD4 ϩ CD25 ϩ T cells in C57BL/6 mice before infection with L. major did not alter the course of infection (data not shown). In three independent experiments, no significant difference in the size of lesions between PC61-treated and control C57BL/6 mice was observed, and both groups resolved their lesions. Furthermore, the level of cytokines produced (no IL-4, high level of IFN-␥) in the draining lymph nodes of both groups of mice did not differ. However, parasite load in the footpads of CD25 ϩ T cell-depleted C57BL/6 mice 5 wk after infection was 10 times lower than in control C57BL/6 mice infected with L. major simultaneously; 8 wk after infection parasites in the lesions of PC61 treated mice disappeared almost completely (75% of mice with no parasites detectable and 25% of mice with 3-10 parasites/footpad) while C57BL/6 mice not depleted of CD25 ϩ T cells still had 0.5-6.7 ϫ 10 3 parasites per lesion.
The early IL-4 response to L. major is significantly enhanced in BALB/c mice depleted of CD4
We have previously documented a burst of IL-4 mRNA expression in draining lymph nodes of BALB/c mice within 1 day of infection with L. major (11). This early IL-4 burst occurs in a restricted population of LACK-reactive CD4 ϩ T cells expressing the V␤4V␣8 TCR chains (28) . The causal relationship between this early IL-4 response and subsequent Th2 cell maturation in BALB/c mice was demonstrated (15).
To investigate whether or not CD4 ϩ CD25 ϩ regulatory T cells control the early IL-4 mRNA response to L. major, BALB/c mice treated or not with 1 mg of anti-CD25 PC61 mAb were inoculated, 3 days later, with L. major in one hind footpad. Sixteen hours after infection, total mRNA from draining lymph nodes was analyzed for IL-4 mRNA expression using a semiquantitative RT-PCR. Compared with infected mice not treated with PC61 mAb, higher levels (6 -10 times) of IL-4 mRNA transcripts were consistently observed in lymph nodes of CD4 ϩ CD25 ϩ T cell-depleted mice (Fig. 2) . This increase in IL-4 mRNA was confirmed in five independent experiments where, 16 hr after infection with L. major, the level of IL-4 mRNA measured in PC61-treated mice was significantly higher ( p ϭ 0.0001) compared with that measured in BALB/c mice that were not injected with the mAb. The IL-4 mRNA was detected only in the V␤4V␣8 CD4
ϩ T cell population (data not shown). Comparable results were obtained by real-time PCR, 16 h after infection with L. major (data not shown). It is noteworthy that in the absence of infection with L. major, treatment of BALB/c mice with the mAb PC61 did not affect the basal level of IL-4 mRNA transcripts. In five independent experiments, no statistically significant difference was observed between the level of IFN-␥ transcripts measured in draining lymph nodes of BALB/c mice depleted or not of CD25 ϩ cells 16 h after infection with L. major (data not shown).
Demonstration of the inhibitory role of CD4
ϩ CD25 ϩ regulatory cells on disease progression and Th2 cell development using an adoptive cell transfer system
In addition to depleting cells from the minor CD4 ϩ CD25 ϩ regulatory subset, treatment of mice with the anti-CD25 mAb PC61 could also lead to depletion of other CD4 ϩ T cells induced to express CD25 following activation by L. major Ags. To circumvent this potential problem, we directly tested the regulatory potential of CD4 ϩ CD25 ϩ cells using an adoptive cell transfer system originally described by Mitchell et al. (29) and subsequently by others (30 -32 (Fig. 3A) . Estimation of the numbers of viable parasites in lesions by limiting dilution analysis substantiated these findings because 10 wk after infection, the parasite burden was 3-5 log higher in lesions of SCID mice reconstituted with CD25 ϩ celldepleted spleen cells compared with mice reconstituted with unseparated spleen cells (Fig. 3B) . Susceptibility of these mice to L. major was correlated with ultimate Th2 cell development because after stimulation with L. major in vitro their lymph node cells produced elevated amounts of IL-4 and reduced amounts of IFN-␥ (Fig. 3C) .
It is noteworthy that reconstituted SCID mice were infected with L. major 5 days after adoptive cell transfer, a time when significant repopulation of lymph nodes with donor cells had occurred. Using flow cytometry and establishing a ratio of 10 5 bacterial count microbeads to lymphocytes, an equivalent number of cells was measured in the lymph nodes and spleens of SCID mice reconstituted with CD25
ϩ -depleted or undepleted spleen cells 5 days after reconstitution (data not shown).
ϩ CD25 ϩ regulatory cells on the early IL-4 response to L. major in BALB/c mice using an adoptive cell transfer system
The requirement for LACK-reactive V␤4 V␣8 CD4 ϩ T cells and the IL-4 they produce, within one day of infection with L. major for subsequent Th2 cell development and expression of a susceptible phenotype in BALB/c mice, has been demonstrated (13, 14) . Therefore, experiments were designed to determine whether the susceptible phenotype of mice reconstituted with CD25 ϩ cell-depleted spleen cells and the resistant phenotype of SCID mice reconstituted with 10 7 BALB/c spleen cells were correlated with the expression of an early IL-4 mRNA burst in response to L. major or lack thereof, respectively. Five days after reconstitution with either 10 7 total or CD25-depleted spleen cells, SCID mice were infected with 3 ϫ 10 6 L. major and 16 h later IL-4 transcripts were quantitated in their draining lymph node cells by RT-PCR. The lymph nodes of SCID mice that received CD25-depleted BALB/c spleen cells showed a rapid increase in IL-4 mRNA similar in magnitude to that observed in BALB/c mice simultaneously infected with L. major. In contrast, no increase in IL-4 mRNA expression was observed in lymph node cells of mice that received an equivalent number of BALB/c spleen cells not depleted in CD4
ϩ CD25 ϩ regulatory T cells (Fig. 4) . These results show that in this model system, as in BALB/c mice, an early IL-4 burst precedes Th2 cell maturation. Experiments aimed at identifying the cellular origin of the rapid IL-4 mRNA burst in SCID mice reconstituted with CD25 ϩ cell-depleted spleen cells have revealed that it occurred in 
CD4
ϩ T cells that express the V␤4 TCR chain (A. Gumy, unpublished data).
Because total lymphocyte count from the popliteal lymph nodes of CD25 ϩ depleted mice was higher than that from nondepleted mice for the same duration of infection (data not shown). Therefore, we tested whether draining lymph node cells from CD25-depleted and nondepleted BALB/c mice infected with L. major differed in their proliferative capacity to specific stimulation in vitro. As shown in Fig. 5 , cells from CD25-depleted mice showed a higher rate of thymidine incorporation in response to L. major or anti-CD3 in culture. This was also observed in nonrestimulated cells as a higher background. Surprisingly, this difference was still apparent 5 wk after infection, at least for lymph node cells stimulated with anti-CD3, suggesting that the state of activation of CD4 ϩ cells in the periphery has been altered by the absence of the CD4 ϩ CD25 ϩ T cells in vivo during the initial infection with L. major.
No preferential expansion of V␤4 ϩ cells was found when cultured cells were stained and tested by flow cytometry (data not shown), suggesting that the state of activation rather than the preferential expansion of V␤ subsets leads to the increased proliferation observed in lymph node cell cultures from mice depleted of CD4 ϩ CD25 ϩ T cells. Upon stimulation with L. major in vitro, the proliferative response of lymph node cells obtained 10 wk after infection with L. major from SCID mice reconstituted with 10 7 CD25 ϩ T cell-depleted splenocytes was clearly higher than that observed in lymph node cells of similarly infected SCID mice reconstituted with the same number of total spleen cells (Fig. 6) . infected nonreconstituted SCID mice, SCID mice reconstituted with 10 7 unseparated spleen cells, and BALB/c mice treated or not with anti-IL-4 mAb. Monitoring the development of lesions in mice from these various groups clearly showed that, similarly to BALB/c mice, treatment with anti-IL-4 renders SCID mice reconstituted with 10 7 spleen cells devoid of CD25 ϩ T cells fully resistant to L. major (Fig. 7A) . Furthermore, the numbers of parasites recovered after culture in vitro of footpad tissues, removed 12 wk after infection, confirmed that parasite growth was controlled in these mice (2 ϫ 10 3 L. major/footpad lesion vs 3 ϫ 10 8 in control mice not treated with anti-IL-4 mAb). Resistance to infection was correlated with the ultimate development of Th1 responses 12 wk after infection. Results in Fig. 7B show that SCID mice reconstituted with spleen cells free of CD25 ϩ cells and treated with anti-IL-4 mAb exhibited a Ͼ10-fold decrease in the amounts of IL-4 transcripts in their draining lymph node lymphocytes compared with similarly infected SCID mice not treated with anti-IL-4 mAb. As previously observed, it is noteworthy that the responses of the mice from the various groups could not be discriminated on the basis of the amounts of IFN-␥ transcripts. Comparable results were obtained when supernatants of specifically activated lymph node cells were analyzed for the accumulation of IL-4 or IFN-␥ (data not shown).
Neutralization of IL-4 prevents
Importantly, the anti-IL-4 treatment did not affect the proliferation rate of transferred CD4 ϩ T cells in reconstituted SCID mice as assessed by determining the CFSE profile in draining lymph node cells 15 days after transfer of CFSE-labeled spleen cells, i.e., 10 days after infection with L. major (data not shown).
Discussion
In this report, we show that compared with normal BALB/c mice, BALB/c mice depleted of CD4 ϩ CD25 ϩ regulatory T cells three days before infection with L. major develop significantly more severe lesions that contain higher numbers of parasites. This enhanced disease progression was correlated with the faster development of robust IL-4-producing CD4 ϩ T cell responses. In the absence of CD4 ϩ CD25 ϩ regulatory T cells, the early IL-4 transcriptional burst seen in BALB/c mice within 1 day of infection with L. major was significantly enhanced. Inhibition of the activation of MHC class II-restricted parasite-specific CD4 ϩ T cells due to the persistence of the anti-CD25 PC61 depleting mAb is unlikely to account for the observed effects. Indeed, SCID mice reconstituted with BALB/c spleen cell populations, depleted of CD25 ϩ regulatory T cells in vitro, also exhibited increased levels of IL-4 transcripts in the draining lymph nodes 1 day following infection with L. major, enhanced disease progression and Th2 cell development.
Studying the requirement for IL-2 signaling on the progression of lesions in BALB/c mice infected with L. major, others have reported that the biweekly administration of anti-IL-2R␣ (CD25) mAb PC61 during the first 4 wk of infection renders BALB/c mice resistant (35) . In these experiments, it is likely that persistent blocking of the IL-2R and/or depletion of CD4 ϩ T cells, that are induced to express the IL-2R␣ chain following specific activation, preferentially interfered with the expansion of recently activated CD4
ϩ Th2 cells because IL-2 signaling has been reported to be required for the establishment and maintenance of Th2 responses (35) (36) (37) . Interestingly, in this study restricting the administration of the anti-IL-2R␣ PC61 mAb to the first day of infection with L. major either did not modify or sometimes exacerbated disease progression (35) . Because we show in this study that an interval of 3 days after the injection of PC61 mAb is required for the maximal depletion of CD25 ϩ T cells, it is likely that when the anti-CD25 mAb is administered the day of infection, the exacerbating effect on disease progression varies depending upon the numbers of CD25 ϩ regulatory T cells available. In this context, at least in vitro, the degree of suppression mediated by CD4 ϩ CD25 ϩ regulatory T cells has been demonstrated to be proportional to the numbers of regulatory T cells (34) .
Even in the absence of antigenic stimulation, the results in this report show an increased proliferation and repopulation of lymph nodes by adoptively transferred CD4 ϩ T cells in syngeneic SCID recipients when the CD4 ϩ
CD25
ϩ population was removed from the spleen cell inoculum before transfer. That CD25 ϩ regulatory cells regulate the size of the peripheral lymphoid compartment is also supported by several other observations. Thus, a shortage of CD25 ϩ regulatory T cells has been reported in IL-2-or IL-2R␣-deficient mice that exhibit a dysregulation of both the size and the content of their peripheral lymphoid compartment resulting in autoimmunity (38 -39) . Similarly, the activated/memory CD45RB low CD4
ϩ T cell population, containing natural regulatory T cells, was clearly shown to limit the peripheral expansion of naive CD45RB high CD4 ϩ T cells when both CD4
ϩ T cell subpopulations were transferred into syngeneic Rag-2 0/0 recipients (40). Furthermore, depletion of CD25 ϩ cells in vivo with the PC61 mAb led to an increased expansion of adoptively transferred C57BL/6 spleen T cells in syngeneic nude mice (39) . In contrast to naive classical CD4 ϩ T cells that need to be activated to express CTLA-4, CD4 ϩ CD25 ϩ regulatory cells have been shown to express CTLA-4 constitutively (41-43). Blockade of CTLA-4 using anti-CTLA-4 mAb has been reported to decrease the suppressive capacity of CD25 ϩ regulatory T cells in vitro (43) and to interfere in vivo with the ability of these cells to control intestinal inflammation (42, 43) . It is presently not known whether the CTLA-4 molecules on CD25 ϩ regulatory T cells prevent interaction between the CD28 molecules on target cells with the B7 (CD80/CD86) molecules on APC (43) or, alternatively, cross-linking the CTLA-4 molecules on CD25
ϩ cells results in TGF-␤ production (44) . In this context, treatment with anti-CTLA-4 mAb has been shown to exacerbate disease progression and to lead to enhanced Th2 responses in BALB/c mice infected with L. major (45) effects similar to those reported in this study following depletion of CD4 ϩ CD25 ϩ regulatory T cells. Using different antigenic systems, other studies have shown that mice expressing a transgenic TCR on a CTLA-4 Ϫ/Ϫ background preferentially develop Th2 responses and conversely that signaling through CTLA-4 inhibits Th2 maturation (46) . Thus CTLA-4 would limit the magnitude of Th2 differentiation. Therefore, the similarities between the effects observed either in the absence of CD4 ϩ CD25 ϩ regulatory T cells or following the blockade of CTLA-4 support the hypothesis that CTLA-4 may play a role in the suppressive activity of CD4 ϩ CD25 ϩ regulatory T cells. The suppressive capacity of the CD4 ϩ CD25 ϩ population likely results, at least in part, from its ability to inhibit IL-2 transcription and IL-2 production in the target T cell population (47) . As a result, these responder cells fail to proliferate and undergo cell cycle arrest at the G 0 /G 1 phase (47 ϩ regulatory T cells without affecting the proliferation rate of the transferred CD4 ϩ T cells. Therefore, we believe that an excessive production early after infection of the IL-4, necessary for instructing further Th2 cell development, by LACK-reactive V␤4V␣8 CD4 ϩ T cells is a major consequence of the depletion of CD25 ϩ regulatory T cells in this experimental system. The requirement for LACK-reactive V␤4V␣8 CD4 ϩ T cells and the IL-4 they produce during the first day of infection with L. major for subsequent Th2 cell maturation and disease progression in susceptible BALB/c mice has been firmly established (13, 15, 28) . The mechanism by which CD25 ϩ regulatory T cells down-regulate IL-4 production by LACK-specific V␤4V␣8 CD4 ϩ T cells is not known. However, given our recent findings that this early IL-4 response to L. major is regulated by IL-2 (A. Gumy, unpublished data), it is possible that a CD25 ϩ regulatory T cell-mediated inhibition of IL-2 gene transcription could affect IL-4 production.
Although anergic in terms of proliferation, CD4 ϩ CD25 ϩ regulatory T cells have been reported to express their suppressive activity at concentrations of Ags significantly lower than those necessary for activation of other (naive) T cells (34) . In this context, results from elegant experiments recently indicated that the development of CD4 ϩ CD25 ϩ regulatory T cells requires higher avidity of their TCR for MHC class II/self-peptides than other (naive) T cells (52) . The LACK Ag of L. major is the Leishmania homolog of mammalian RACK1 and there is some degree of homology between the two proteins, particularly within the region of the immunodominant I-A d epitope of LACK eliciting the rapid IL-4 response by V␤4V␣8 CD4 ϩ T cells in BALB/c mice (12, 14) . It is thus tempting to speculate that some CD4 ϩ CD25 ϩ regulatory T cells expressing TCR with high avidity for a peptide in mammalian RACK1 are positively selected in the thymus and readily activated in the periphery to exert suppression following injection of LACK. The mechanism by which regulatory CD4 ϩ CD25 ϩ T cells suppress IL-4 production by LACK-reactive cells remains elusive. However, if regulatory CD25 ϩ T cells and V␤4V␣8 CD4 ϩ T cells recognize their specific epitope on the same APC, the possibility that activated regulatory CD25 ϩ T cells renders this APC unable to provide costimulatory signals necessary for IL-2 transcription in V␤4V␣8 CD4 ϩ T cells is attractive. In this context, some observations already strongly suggest that the CD25 ϩ suppressor T cell population acts on APC (17) .
Noteworthy, depletion of CD25 ϩ T cells in C57BL/6 mice before infection with L. major had no significant effect on the resolution of lesion; however, the transient absence of CD25 ϩ regulatory T cells resulted in reduced parasite numbers within lesions and suppressed almost totally the parasite reservoir remaining normally in clinically cured C57BL/6 mice. CD4 
ϩ may produce the IL-10 recently found necessary for the persistence of parasites in clinically cured animals (55) . Additional experiments are needed to further decipher the mechanism of action for CD4 ϩ
ϩ in strains of mice resistant to infection with L. major.
In summary, in this study we have shown that regulatory T cells, highly efficient in controlling self-reactive effector T cells and preventing autoimmunity, are also able to restrain the development of detrimental Th2 responses to an intracellular parasite in genetically susceptible hosts. Defining the fine specificities of CD25 ϩ regulatory T cells, understanding the cellular and molecular mechanisms involved in suppression and their role in controlling pathologies induced by specific Th subsets remain important issues that deserve further studies. This knowledge could ultimately lead to the design of new strategies for manipulating the development of effector responses to the host's benefit.
